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For many women, emergency contraceptive pills (ECPs) offer an opportunity to prevent unintended 
pregnancy following contraceptive method failure, rape or unprotected sex. Access to this safe, effective 
option remains an essential element of women’s quality reproductive healthcare. However, ECPs remain 
inaccessible across much of the world, as both supply and demand constraints undermine potential 
clients’ ability to effectively use the method. This is particularly true in developing countries, where 
limited commodity supplies, provider competency, public awareness, and misinformation routinely 
coalesce to restrict the availability of ECPs. While ECPs have been introduced on a pilot basis in many 
countries, their effective integration into both the public and private sectors has lagged in the face of 
competing priorities. Successful interventions are guided by the principle that provision of ECPs is not 
exclusively the responsibility of government family planning programs, and so seek to mainstream 
delivery of ECPs by developing linkages with private sector providers and pharmacies, the HIV/AIDS 
sector, and sexual assault services.
As with the introduction of most contraceptive methods that are new to a national program, the 
process of successfully introducing ECPs into a country’s health care system is a complex and usually 
protracted undertaking. This handbook is designed to provide step-by-step guidance for introducing and 
mainstreaming ECPs within a variety of country contexts, in a manner that will be responsive to their 
diverse needs and resource availability.
Production of this handbook was a collaborative effort between two projects of the Population Council’s 
Reproductive Health Program: the Frontiers in Reproductive Health (FRONTIERS) project, funded by 
USAID; and the ECafrique network, funded by the William and Flora Hewlett Foundation. It synthesizes 
systematically documented programming practices drawn from a range of experiences in Africa, Asia, 
and Latin America and the Caribbean over the past decade. The handbook has been compiled from four 
unpublished reviews conducted by FRONTIERS (Muteshi and Keesbury 2007; Fernández and Vernon 2007; 
Khan and Hossain 2007; Fernández et al. 2008) and from selected documents that provide complementary 
guidance specific to the delivery of ECPs after their introduction and mainstreaming (e.g. PATH 2004; 
Pathfinder 2007).
The intended audience for this handbook includes reproductive health (RH) program managers and 
government and NGO policy makers. It can be used in countries where ECPs are not currently available, 
as well as in contexts where the intention is to expand or mainstream access to existing ECP services. The 
handbook:
recognizes the different needs of diverse segments of the population, and places additional 
emphasis on targeting ECP services to “special groups,” which include rape survivors and 
adolescents.
seeks to present an overall process that can be adapted to specific contexts and that is based on 
documented successful experiences in a range of contexts.
guides policymakers and program managers through the continuum of ECP programming: from 
needs assessments and operations research, to registration, to training, logistics, and ultimately 
mainstreaming through nationwide scaling-up.
The handbook contains four sections:
Introduction	and	Background describes the existing situation of ECP programming around the globe.
Addressing	the	Needs	of	Specific	Populations describes programming approaches designed for specific 
populations. 
Introducing	and	Mainstreaming	ECPs describes five chronological steps for making ECP programming an 
integral component of a national RH program.
The Bibliography lists useful resources for ECP programming.
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What is emergency contraception?
Emergency contraception (EC) is the term 
given to contraceptive methods that can be 
used by women in the first few days following 
unprotected intercourse to prevent an unplanned 
pregnancy (WHO 1998). EC should not be 
recommended or used as a regular contraceptive 
method. Emergency Contraceptive Pills (ECPs) 
contain higher doses of the hormones used in 
oral contraceptive pills. ECPs are effective in 
preventing pregnancy when taken within 120 
hours (five days) of unprotected sex, although 
they are more effective the earlier they are taken. 
ECPs are sometimes inaccurately called “the 
morning after pill.”
Why are ECPs important?
ECPs provide a unique opportunity for 
preventing pregnancy after unprotected 
sex that no other contraceptive method 
can provide.
ECPs can reduce the incidence of 
unintended pregnancy, which may 
otherwise result in an unsafe abortion.
ECPs are an important element in 
post-rape care as well as an essential 
component of reproductive health.
When does a woman need to use 
ECPs?
ECPs are used after unprotected sex. This can 
include the following situations:
when no contraceptive method has been 
used; 
when a condom breaks;
when a woman forgets to take oral 
contraceptive pills for two or more days, 
or delays a scheduled injectable for more 
than two weeks; or
when a woman is raped/coerced into sex 
and is not currently using contraception.
ECP options
Dedicated	progestin-only	ECPs	
(specifically	formulated	and	packaged	
ECP	product): 1.5mg levonorgestrel 
taken in a single	dose	within	120	
hours	of unprotected intercourse, in 



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either one or two pills. If a two-pill 
dose is used (0.75mg each), these may 
be taken together or individually no 
more than 12 hours apart.
Combined	regimen	of	progestin	and	
estrogen	(also	known	as	the	Yuzpe	
method): at least 100mcg of ethinyl 
estradiol and 500mcg of levonorgestrel 
taken as a first	dose	within	120	hours	
of unprotected intercourse, followed 
by a second dose 12 hours later. This	
regimen	can	be	made	by	choosing	
appropriate	birth	control	pills	and	
calculating	the	number	of	pills	
needed	for	each	dose. 
Progestin-only	oral	contraceptive	
pills	(OCPs): taken as a first	dose	of	20	
pills	within	120	hours of unprotected 
intercourse, followed by a second	dose	
of	20	pills	12	hours	later. This ECP 
option is not generally recommended 
due to the large number of pills 
required, but can be a back-up option 
in the absence of the other options.
A WHO multi-center randomized trial in ten 
developed and developing countries found a 
single 1.5 mg dose of levonorgestrel to be as 
effective in reducing the risk of pregnancy as two 
0.75 mg doses taken 12 hours apart. Side effects 
did not differ between the regimens (von Hertzen 
et al. 2002). According to the International 
Consortium for Emergency Contraception 
(ICEC), “providers should advise women to take 
a single 1.5 mg dose of the levonorgestrel-only 
ECP regimen” (ICEC 2003a). Option #1 simplifies 
ECP use, but if not available, options #2 and #3 
should be considered.
Efficacy and side effects of ECPs
The efficacy of ECPs in preventing pregnancy is 
lower than the efficacy of regular contraceptive 
methods. The figures below reflect the risk 
of pregnancy in the 72 hour period following 
unprotected intercourse.
Progestin-only:
Reduces the risk of pregnancy for that 
single act of intercourse by 60-90 percent 
(WHO et al 2005).
Side-effects: nausea in 23 percent of 
women and vomiting in 6 percent (WHO 
1998).
2.
3.
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Combined	estrogen	and	progestin:
Reduces the risk of pregnancy for that 
single act of intercourse by 75 percent.
Side-effects: nausea present in 43 percent 
of women and vomiting in 16 percent 
(ICEC 2004).
Mechanism of action
The precise mechanism of action of ECPs 
depends on the time in a women’s menstrual 
cycle, when intercourse occurred, and when 
the ECPs are taken. ECPs cannot interrupt an 
established pregnancy or harm a developing 
embryo.  According a joint statement issued 
by the ICEC and the International Federation of 
Gynecology and Obstetrics (FIGO), levonorgestrel-
only contraceptive pills prevent pregnancy by 
either: 1) inhibiting or delaying an egg from 
being released from the ovary when taken before 
ovulation; or 2) possibly preventing the sperm 
and the egg from meeting by affecting the 
cervical mucus or the ability of sperm to bind to 
the egg. 
Most studies show that levonorgestrel-only ECPs 
do not change the histological or biochemical 
characteristics of the endometrium, indicating 
that they have no mechanism to prevent 
implantation (ICEC and FIGO 2008).
Knowledge of how ECPs work is central to 
understanding the crucial difference between 
emergency contraception and early medical 
abortion. Confusion between the two has 
occasionally led to unjustified rejection or 
denouncement of ECPs. First, these are different 
compounds and categories of drugs. Secondly, 
ECPs are effective only in the first 120 hours 
after sexual intercourse – before implantation 
of the fertilized egg in the uterus begins, which 
is when pregnancy begins according to the 
medical definition. In contrast, medical abortion 
is the termination of early pregnancy through 
the dislodging of the implanted, fertilized egg. 


ECPs should not be confused with misoprostol, 
mifepristone or RU486, which do have an 
abortive effect.  
Side effects
The main side effects reported include:
Nausea and vomiting are the most 
common side effects.  
Bleeding disturbances or spotting.
Other possible effects include headaches, 
dizziness, fatigue, and breast tenderness.
Most side effects generally disappear within 
24 hours of taking the pills. To reduce the effects 
of nausea, ECPs can be taken with food, and 
anti-emetics can help women who have a history 
of nausea or vomiting when taking pills with 
hormonal content.  If a woman vomits less than 
two hours after taking a dose of ECPs, the dose 
should be repeated. In cases of severe vomiting, 
EC can be administered vaginally (ICEC 2004). 
Repeat use
There is no evidence that repeated use of ECPs is 
harmful for most women (Abuabara et al. 2004), 
apart from the enhanced risk of unintended 
pregnancy if ECPs are used routinely instead 
of a regular contraceptive method. ECPs are 
safe even when used more than once in a cycle 
(ICEC 2003b); however, repeated use of ECPs is 
not recommended for women who have sexual 
intercourse regularly or who may be exposed to 
STI/HIV infection. Other contraceptive methods 
are more effective at preventing pregnancy as 
well as more affordable, and condoms have 
the added benefit of protecting against STIs. 
If a client reports repeat use of ECPs, the 
health provider is advised to counsel her about 
switching to a regular contraceptive method.
ECPs and STIs, including HIV
ECPs do not protect against STIs, including HIV.  
If a woman has been raped, it is important to 
give her post-exposure prophylaxis (PEP) for 
STIs, within 72 hours of the incident. Routine 
prophylaxis for HIV is a matter of considerable 
controversy and is not a universally accepted 
standard of practice. Health workers should refer 
to local protocols dealing with HIV PEP if they 
exist (WHO 2003a).
What to do after using ECPs
Providers can use the opportunity of providing 
ECP to counsel clients on future safe sexual 
behaviors. They should recommend that clients:



“Emergency contraception is not the same 
as early medical abortion.  EC is effective 
only in the first few days following 
intercourse before the ovum is released 
from the ovary and before the sperm 
fertilizes the ovum.  Medical abortion is 
an option for women in the early stage of 
an established pregnancy, but requires a 
different drug from levonorgestrel”  
(ICEC and FIGO 008).
Use a barrier method or abstain from 
sexual intercourse until next menses. 
Do not use ECPs as a regular 
contraceptive method.
Begin using a regular contraceptive 
method (see table below).
Providers can also counsel or refer clients for 
family planning or other reproductive health 
services, especially for rape survivors who 
need immediate medical management and 
psychosocial care (see section below).
The bridging role of ECPs
Bridging to regular contraceptive methods
The moment when ECPs are provided presents 
an important opportunity to “bridge” clients 
onto a regular and more effective contraceptive 
method by communicating information about 
other available methods about the importance 
of dual protection (including male and female 
condoms) and about the correct and consistent 
use of contraception. A study in Bangladesh 
shows that, after initial use of ECPs (primarily 
because of method-use failure), the proportion of 
women using a regular method of contraception 
increased from 72 to 93 percent (Khan and 
Hossain 2008). In India, a follow-up of users six 
months after they had used ECPs for the first 
time showed that use of a regular family planning 
method increased significantly from 67 to 79 
percent after using ECPs (Kumar et al. 2007).
Bridging to other reproductive health services
Provision and use of ECPs can also act as a 
platform for communicating a range of sexual 
and reproductive health messages and services to 
clients, including referrals for other reproductive 
health services. In Kenya for example, 62 percent 
of FP providers gave additional services to their 
EC clients even without a formal emphasis 
during training on “bridging.” Most often, these 
included HIV/STI counseling or referrals for 


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testing. Notably, nearly half of those counseled 
on FP accepted a new or different method, most 
often injectables or male condoms (Keesbury, 
Owino, and Bradford 2007). Provision of ECP can 
also reinforce HIV prevention efforts including 
serving as a critical back-up method for HIV-
positive women or discordant couples in cases 
of method failure, and for those wishing to avoid 
the potential of mother-to-child transmission 
(Townsend et al. 2007).
Provision of ECPs in different 
settings
Emergency contraception is now available 
to women in over 140 countries around the 
globe, and over the counter in 44 countries 
(ICEC 2008). Depending on national laws, it 
can be provided through government, NGO 
and private clinics, private sector pharmacies 
and physicians, community health agents, and 
other types of service delivery points. Points 
of access vary, depending on the strength of 
public health systems and the penetration of 
the private market. In South Asia, for example, 
EC is provided primarily within well-established 
government family planning programs; in Africa, 
pharmacies tend to be the most common source 
of provision; and in Latin America and the 
Caribbean (LAC), it can be found both in public 
and private sector outlets.
However, there are very few developing countries 
in which ECP could be described as being an 
integral and readily available service within the 
national RH program. Those where it is readily 
available include Argentina, Brazil, Mexico, Peru, 
and Bangladesh. In several countries the method 
is more widely available, primarily through 
the commercial and NGO sectors rather than 
the public sector; however, for the majority 
of countries it is either not widely available 
or available primarily to meet the needs of 
women in specific situations, such as post-rape 
or university settings. This diversity raises the 
possibility of ECPs being associated with use by 
particular groups of women with specific needs 
only (in Ecuador the public sector provides ECPs 
only to rape survivors), and not as a method that 
may be of use to the general population following 
unprotected sex or method failure. In countries 
where there is substantial political or religious 
opposition to making ECPs more widely available, 
introducing it as a service for particularly 
vulnerable women, such as rape survivors, can 
serve as the basis for scaling up the service once 
introduced.
The primary goal of this handbook is to provide 
guidance on programmatic approaches to 
mainstreaming ECPs within a national RH 
Method When to start
Condom Immediately after ECP use - condoms 
provide dual protection against 
pregnancy and HIV/STIs
Oral The day after nd dose of ECPs, or 
within -7 days after menses
Injectable
Within -7 days after mensesIUD
Implant
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program, so that it becomes as widely available 
as other contraceptive methods. ECPs are 
frequently introduced into a country for specific 
groups of women with a higher unmet need than 
the general population. The following section will 
review the key lessons about programming ECP 
services for use by women with specific needs. 
These include young and unmarried women, 
survivors of sexual assault, and displaced women 
living in refugee camps.
Following this overview of programming for the 
needs of women in specific situations, the greater 
part of the handbook will review the key strategic 
steps that are critical for efforts to mainstream 
ECPs to increase their availability for the general 
public. Clearly, most countries may need to 
mainstream ECP provision to increase access 
for the general population while simultaneously 
implementing programs that can meet the needs 
of women in specific situations. The intention of 
producing this handbook is to provide guidance 
that can support RH policymakers and program 
managers to achieve both goals.
Identification of populations with 
specific needs
Unintended pregnancy can place a burden 
on any woman, no matter what her situation. 
However, there are women in certain situations 
who are more vulnerable, both individually and 
socially, for whom EC can play an especially 
important role in maintaining their physical and 
psychological health by preventing an unintended 
pregnancy. In this section we review three of the 
populations whose needs may be better met by 
providing ECPs through specific delivery systems: 
survivors of rape, unmarried young women, and 
women living in refugee settings.
Rape survivors
Pregnancy resulting from rape is almost always 
unintended and traumatic. As a general principle, 
ECPs should be made available to all female 
survivors of rape who are of reproductive 
age or who show signs of secondary sexual 
characteristics, who are not pregnant, and who 
are not consistently using an effective form of 
contraception (WHO 2003a).
A pregnancy test is not required prior to 
providing EC after rape, but pregnancy can be 
ruled out by using a simple checklist (FHI 2007). 
In any case, providers should assure clients that 
even if the woman is pregnant, using ECPs will 
not harm the fetus. As EC must be administered 
within 120 hours of the rape and is most effective 
if used as early as possible, any education 
messages about post-rape services should 
emphasize the critical importance of obtaining 
ECPs (and in high HIV prevalence settings, HIV 
PEP also) as soon as possible after the rape 
(Keesbury, Skibiak and Zama 2006; Keesbury and 
Zama 2007; Vernon, Schiavon, and Llaguno 1997).
The narrow window of opportunity to reduce the 
risk of a pregnancy after rape requires that ECP 
information and services are provided at the first 
point of contact (FPC) with a rape survivor, or as 
soon as possible afterwards. The first point of 
contact varies considerably, but is usually either: 
(1) the place where the crime is first reported, 
most often at a police station, social services or 
public prosecutor offices, legal aid agencies or 
women’s refuges; or (2) at the place where the 
survivor goes for treatment (either before or 
after reporting the crime), such as outpatient 
or emergency units at health facilities. Some 
countries have, or are developing, specialist 
centers that can provide all medical, legal, 
psychological, and other support for survivors 
at one point of contact (e.g. the Thuthuzela Rape 
Centers in South Africa [UNICEF 2008]).
 
In several countries (e.g. Ecuador, Guatemala, 
Mexico, and Zambia), ECP counseling and services 
have been introduced in police precincts and 
rape care centers. Experience shows that staff in 
these centers require more extensive training in 
counseling rape survivors than health staff and 
may require special approvals and support from 
the health sector. Having this service included in 
guidelines and protocols is essential for ensuring 
that the staff consistently deliver the services. 
When the ECPs themselves are not provided, 
these FPCs should refer survivors to pharmacies 
or clinics where they can obtain the pills and 
be provided written instructions on how to use 
them or, if available, to rape care centers where 
a broader set of needs can be cared for (Vernon, 
Schiavon, and Llaguno 1997; Taracena and 
Brambila 2001; Keesbury and Zama 2007).
Establishing ECP services for rape survivors 
at these FPCs may require training providers 
as community-based or employer-based 
contraceptive distributors under national 
guidelines. At a minimum, staff and managers 
should be trained on the following:
The characteristics of ECPs
Identifying which rape survivors should 
be provided with ECPs
Counseling survivors about their options 
and providing ECPs or a referral for them
After provision, referring for STI/HIV PEP 
and medical and psychological trauma 
management (if not already received)
Depending on the individual’s preference 
and the national legal framework, 
opening or a referral for opening a 
criminal case
Provision of ECPs at the FPC is strongly 
recommended over referring to another location 
because of the critical need for its immediate use, 
especially in situations that lack readily available 
transportation (Vernon, Schiavon, and Llaguno 
1997; Vernon 1998; Kestler and Ramirez 2004; 
Keesbury and Zama 2007).
Female survivors of sexual violence often 
sustain physical injuries and after the assault 
are more likely than other women to have 
unintended pregnancies, report symptoms of 
reproductive tract infections, have multiple 
partners, and be less likely to use condoms 

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and other contraceptives (IFPP 2004). EC is only 
one component of a comprehensive post-rape 
care “package” of services necessary to reduce 
the range of possible consequences of sexual 
violence. As far as is possible, a comprehensive 
and integrated care package should be available, 
either in a single venue (e.g. the Thuthuzela 
model) or, more commonly, through a system of 
coordinated referrals among specialized units.
Young women
Young people are defined by WHO as those aged 
between 10 and 24 years, thereby including both 
adolescents (aged 10-19 years) and youth (aged 
15-24 years). For most young people, this is a 
time of sexual initiation and experimentation, 
often characterized by infrequent, unplanned, 
and sometimes non-consensual encounters. 
By its very nature, this type of sexual activity 
is frequently unprotected or insufficiently 
protected against both pregnancy and STIs. 
Ensuring access to and use of ECPs can be a 
critical component in any RH program’s efforts 
to reduce unintended pregnancies among this 
population. Young people may thus constitute 
an important and growing population to be 
reached with ECP services by a national RH 
program.  Evidence from Kenya suggests that 
young people constitute as many as 80 percent 
of all public sector ECP clients, and 49 percent of 
those purchasing the method from pharmacies 
(Keesbury, Owino, and Bradford 2007).
Young people are not a homogeneous population, 
even within a particular country setting, and so 
ECP programming strategies to reach them need 
to be flexible. In most situations, ECP information 
and services should be made available through 
the same structures and programs as other youth 
reproductive health information and services, 
such as adolescent-friendly clinics, community-
based programs and, in some settings, school-
based programs. Because many adolescents 
may feel shy, distrust established services, lack 
money, and have less knowledge than older 
people, it is even more important that ECP 
services for young people have the recommended 
characteristics of quality contraceptive services in 
general, including:
Privacy and confidentiality
Easy accessibility
Reasonably priced services and supplies
Convenient and flexible schedules
Sensitive and approachable staff trained 
to counsel adolescents
ECP programming for adolescents through 
existing structures requires planning, budgeting, 
and undertaking activities that enable the 
inclusion of messages and informational 
materials within communications strategies, 
training of existing staff, and easy delivery 
and maintainance of commodity supplies. For 
example, within secondary schools, information 
about ECPs could be included within a broader 
curriculum covering sexual and reproductive 
health, or in special ECP-focused sessions that 
include this topic could be held for students, 
teachers, and parents. In tertiary, and some 
secondary education facilities, existing student 
health services can be equipped to provide 
ECPs, along with counseling and services for 
contraception and STI/HIV prevention. For 
further information on youth-friendly services 





Providing ECPs at the first point of contact for rape survivors
 
In Zambia, the majority (9%) of rape survivors in the Copperbelt region go to the police before seeking healthcare 
(Keesbury and Zama 007). Moreover, although 8 percent of all survivors managed to get to a health facility within 
the time window for ECPs, only 7 percent actually received ECPs from hospital staff. These results encouraged the 
Ministry of Health to train police officers as community-based ECP distributors. Estimates suggest that enabling 
police to provide ECPs could benefit up to 9 percent of rape survivors, with little difference between rural and 
urban locations (Keesbury, Skibiak, and Zama 00).
However, the provision of ECPs at FPCs that do not have medically qualified staff may present certain challenges. 
In Bangladesh and India, although police stations are a common FPC, police refused to stock or provide ECPs and 
only reluctantly agreed to supply information about ECPs to survivors (Khan et al 008).
Providing brochures on ECPs at the FPC rather than providing the method itself was used in Mexico because in the 
absence of official guidelines, staff at public agencies were afraid they could be charged with providing abortions 
and providing drugs without a medical license (Vernon, Schiavon and Llaguno 998).  Even when non-medical FPCs 
do commit to providing ECPs, compliance with service delivery might vary significantly, and constant monitoring 
and supervision of activities is required.
7see Youth Net/FHI (2004), and for resources to 
guide ECP programming for young people see 
Beitz et al. (2003) and Parker (2005).
Integrating ECP services with related youth-
focused activities can also be an effective way to 
increase the range and impact of ECP messages, 
although a stand-alone project or program on 
ECPs for adolescents and youth may not be 
acceptable or feasible in many countries.
Further methods of reaching young people with 
information about ECPs include:
identifying and using media and 
information channels that are accessible 
to the youth population. For example, 
newspapers, hotlines, youth journals, 
websites and advertisements for events 
attended by youths.
making ECPs an over-the-counter (OTC) 
product available to young people. This 
would dramatically reduce medical 
barriers in accessing ECPs.
encouraging and training pharmacists to 
stock ECPs and to disseminate correct 
information to their clients, particularly 
youth.
Women living in humanitarian 
settings
Relatively little is known about how best to 
provide reproductive health services, including 
ECPs, in humanitarian settings. Service delivery 
to refugees and internally displaced persons 
(IDPs) tends to be adapted from models designed 
for stable communities, and there is little 
information about how these service delivery 
models are best used or adapted to the needs 
of refugees or IDPs. Moreover, the reproductive 
health status and needs of a refugee woman 
living long-term in a stable camp setting may be 
very different from those of refugees during the 
emergency phase of a crisis, or from IDPs and 
other war-affected groups (McGinn 2000). This 
section reviews some of the issues associated 
with programming ECPs in such settings.
Humanitarian emergencies may flare up in a 
short time period, and, by their very nature, may 
not allow time for intensive and comprehensive 
training of providers, which can include medical 
and paramedical staff as well as traditional 
birth attendants and trained field staff and 
volunteers.  Ideally, providers should be trained 
and sensitized in advance, or, if necessary, by a 
dedicated RH advisor after the response begins 
(Goodyear and McGinn 1998).  Medical staff 
should be trained to provide ECP counseling, 



Reaching young people with 
information about ECPs
A study in Zambia found that pharmacists 
and peer educators were the most frequent 
sources of information on ECPs for 
adolescents, being more widely used than 
clinic-based providers and community-
based contraceptive distributors (Skibiak, 
Chambeshi-Moyo, and Ahmed 00).
In Mexico, the IPPF affiliate MEXFAM 
introduced ECPs into the curricula of all 
reproductive health training courses for 
schools and communities and pioneered 
ECP services in adolescent-friendly 
clinics and in youth peer and community 
programs. Awareness of ECPs among youth 
significantly increased (Vernon and Durá 
00). Displaying posters, distributing 
postcards, and providing telephone hotlines 
have also proven effective in informing 
youth (Givaudan, Fuertes, and Vernon 998; 
Vernon 998; Ellertson et al. 00).
In India, ECPs are now regularly advertised 
on many TV channels and FM radio stations 
popular among young people. The Ministry 
of Health and Family Welfare is establishing 
adolescent-friendly sexual and reproductive 
health clinics in rural health facilities and 
urban district hospitals; counseling on 
and provision of ECPs is one of the key 
components (MOHFW 00).
In Kenya, the experience of training 
pharmacists in classroom settings was 
not satisfactory due to a high turnover of 
pharmacists and premature departures 
during training. The study concluded that 
onsite training and the provision of IEC 
materials would be more effective (Beitz et 
al. 00). Another study in Kenya revealed 
that pharmacists do not engage their 
EC clients in broader discussions about 
their health, and therfore lose important 
opportunities to discuss STIs and other 
relevant RH issues (Keesbury et al.).
In Bolivia, training on-site pharmacy clerks 
to provide appropriate and adolescent-
friendly information and services through 
role-playing with groups of adolescents 
substantially increased sales of ECPs 
(Arteaga and La Fuente 00).
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STI screening, and prophylactic treatment to 
rape survivors, along with necessary trauma 
treatment.
Response programs may be required to be 
creative when sourcing providers of information 
and counseling. In the Kibondo camps of 
Tanzania, leaders elected by refugee women 
in the camps were trained to do community 
education and to counsel rape survivors. 
Traditional birth attendants and social services 
paraprofessionals were given violence-sensitivity 
training, which includes basic information on 
ECPs (Goodyear and McGinn 1998).
ECPs should be available right from the beginning 
of a response to a humanitarian crisis. WHO’s 
Inter-Agency Working Group for Reproductive 
Health in Refugee Situations (WHO 2003b) has 
developed a Minimum Initial Service Package 
(MISP) to address the reproductive health needs 
of displaced women and girls, which includes ECP 
as one of the services to be provided. WHO has 
also included ECPs in the “New Emergency Health 
Kit,” a package of basic commodities delivered 
immediately to every newly identified emergency 
site. Program staff working in emergency settings 
should be aware of the need to source, order, and 
distribute ECPs early in the emergency, tasks that 
may be neglected in the hectic first days.
The key barriers to providing ECPs in 
humanitarian settings are similar to those in 
the general population – women’s (and health 
providers’) lack of knowledge about ECPs, 
stigmatization of users, inadequate supplies, 
and provider insensitivity or bias. As in the 
general population, these barriers lead to under-
utilization. Data from refugee camps in seven 
countries show that 54 percent of female rape 
survivors did not receive ECPs within 120 hours 
of an incident in 2007 (UNHCR 2008). With this in 
mind, it is important to consider that to ensure 
compliance, one-dose dedicated ECPs may be 
more appropriate for transient clients.
Limited understanding and knowledge of 
ECPs in refugee camps often mirrors that of 
the pre-crisis population.  A study in Kakuma 
camp in Kenya found that, as in the general 
population, ECPs were widely perceived to be 
abortifacients. Moreover, of the 34 percent 
of women and 27 percent of men who were 
aware of rape cases, only 11 percent knew that 
emergency contraception was available through 
the camp health services, demonstrating the 
need for greater information to be disseminated 
among refugee populations (Muia, Fikree, and 
Olenja 2000). After providing training on EC 
to professional service providers, women’s 
support group leaders, community health 
leaders, community health workers, and family 
planning promoters in Kakuma, knowledge about 
the method more than doubled in the refugee 
population, from 15 to 35 percent (Muia et al. 
2002).
A humanitarian response team may need to 
consider national laws and protocols in advance, 
and take timely steps to advocate for change, if 
appropriate. For example, NGOs in Sudan say that 
they do not advertise services for rape survivors 
because Sudanese law (Article 48) prevents 
doctors from treating rape survivors without a 
referral from the police department. Doctors and 
health personnel can be arrested for violating this 
law and some have been threatened, to prevent 
them from providing services. In Kakuma camp 
in Kenya, despite trained providers increased 
knowledge about EC among refugees, EC services 
could not be institutionalized and contraceptive 
services continued being provided as they had 
been before the training (Muia et al. 2002).
Health kits for emergency situations: 
procurement details
UNFPA. 00. The Reproductive Health Kit for 
Emergency Situations, nd Edition. 
Order from: UNFPA Procurement Service Section, 
0 East nd Street, New York, NY 007, USA.  
Tel: + 9798 
Fax: +  979.
World Health Organization. 998. The New 
Emergency Health Kit 98
Order from: IDA Foundation, P.O. Box 7098, 00 
AB Amsterdam, The Netherlands. 
Tel: + 0 00 
Fax: + 0 08
Website: www.ida.nl/en-us/
World Health Organization. 00. Clinical 
management of survivors of rape: A guide to the 
development of protocols in refugee and internally 
displaced persons situations. Available at: http//:
whqlibdoc.who.int/hq/2002/WHO_RHR_02.08.pdf
9Step 1.  
Registration of a dedicated ECP 
product
In all countries, medical drugs and products 
need to be registered and to comply with 
national requirements before they can be made 
available to the population through public or 
private channels. The overall purpose of these 
regulatory requirements is to ensure the safety, 
efficacy, and quality of all medicines provided to 
the public. If a product is not registered (usually 
determined through a review of policy documents 
and/or interviews with key informants), then the 
process of registration explained below needs to 
be followed. If ECPs are already registered in the 
country, then proceed to Step 2, introduction of 
ECPs. 
The process of product registration usually 
involves the following steps:
Identify partners to register the ECP 
product(s).
Conduct a pre-registration assessment, if 
appropriate.
Select partners and conduct advocacy with 
relevant authority. 
Identify partners to register the ECP product(s)
The registration of pharmaceutical products 
can be a complex and lengthy process involving 
different steps and requirements. For this reason, 
in most countries reproductive health program 
managers have relied on product manufacturers 
and/or local distributors of pharmaceutical 
products to conduct the actual registration 
process and submit the required applications and 
documents. This also has the advantage that by 
involving the commercial sector, the distribution 
of ECP in pharmacies and other commercial 
outlets is achieved. Experience has shown that 
a local non-governmental partner is usually 
needed to undertake the registration process; the 
government agency in charge of medical product 
registration should be consulted for guidance in 
the procedures necessary for product registration 
in the country.
The most commonly required information for 
registering ECPs includes product information, 
manufacturing process, packaging requirements, 
clinical research results, product quality tests, 
and other product-specific information (PATH 
2004). The active compound in ECPs is found in 
other contraceptives available in most countries 
and therefore governmental regulatory agencies 
a.
b.
c.
can usually facilitate the registration of ECPs.  
Technical information on the product should 
be provided by the product’s manufacturer in a 
confidential dossier that is submitted directly to 
the regulatory agency.
 
Conduct a pre-registration assessment, if 
appropriate
A test or assessment may or may not be a 
precondition of product registration. If it is 
required, it is necessary to determine: 
the organization responsible for 
conducting the test (government 
institution or NGO).
the type of test (for example, a 
biomedical or field test).
who is responsible for utilizing the 
findings after the results are available.



Introducing	and	Mainstreaming	ECPs
Regimen advice 
It is important to ensure that, at the time 
of applying for registration, the latest 
available information on the drug is used. 
For example, WHO has currently approved 
one dose of ECP containing .mg 
levonorgestrel. It is therefore advisable 
to register the .mg levonorgestrel 
regimen first, as registering it after 
obtaining approval of the two-dose 0.7mg 
levonorgestrel regimen would require the 
whole process to be repeated. 
Field testing for registration
In Ethiopia, the national Drug Administration 
Control Authority requires that new drugs 
be “field tested” prior to registration. For the 
MOH to introduce ECPs into their method 
mix, it was necessary to conduct in-country 
research. Instead of repeating the existing 
and universally-accepted clinical trials, the 
MOH undertook an operations research 
study. This effort demonstrated both the 
feasibility of providing ECPs in government 
facilities and its acceptability among clients. 
Combined with global clinical data, this 
evidence provided the basis for successful 
registration of the country’s first-ever 
dedicated ECPs in 00 (Keesbury, Aytenfisu, 
and Bradford 007).
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Even if a pre-introduction assessment is not 
required by the government, the evidence 
provided by such an assessment can be used in 
subsequent advocacy campaigns to register and 
incorporate ECPs into the national reproductive 
health program, as well as help to counter the 
potential opposition posed by political and 
religious groups.
In some cases, the national RH program or an 
NGO can facilitate the registration process by 
conducting feasibility studies, market research, 
and/or “willingness to pay” surveys (which 
document the need, market, acceptability, and 
price of the product) and by raising the interest 
of manufacturers and distributors, including RH 
program and regulatory agency managers. 
Select partners and conduct advocacy with 
relevant authorities
Changing policies and influencing programmatic 
decisions can better be achieved if a large 
number of agencies advocate for the change. If 
possible, partners with credibility such as RH 
service delivery organizations, feminist and legal 
aid organizations, MOH managers and donor 
organizations should be engaged in advocating 
for the introduction of ECPs with the relevant 
authority. Advocacy serves to sensitize political 
leadership, raise public awareness, and can 
potentially minimize the risk of community 
objections.  
Step 2.  
Introduction of ECPs into the public 
sector and NGOs
In most countries, the step of registering 
a product is conducted by pharmaceutical 
companies and distributors; therefore, the 
placement of ECPs in private sector pharmacies 
usually follows shortly after registration of the 
product. By contrast, the introduction of the 
product into large public sector and NGO service 
delivery organizations usually requires extensive 
advocacy and technical assistance. In most Latin 
American countries, and in Bangladesh, India, 
Nepal and Pakistan, for example, ECPs were 
registered and available in the private sector 
for several years before their introduction into 
public-sector programs. Experiences from several 
countries show that the process of introducing 
ECPs into public and/or NGO sectors varies 
significantly and so the following guidelines 
serve primarily to serve as a checklist of issues 
to consider when planning the introductory 
process. Moreover, government engagement and 
ownership of the process is essential for creating 
an enabling policy environment. Doing so often 
requires development partners to financially 
support the introductory process, broadening the 
base of national stakeholders and/or developing 
a formal national strategy that the government 
can endorse. The introductory step can include 
the following four activities:
Conduct a diagnostic assessment for the 
introduction/reintroduction of ECPs.
Partner with stakeholders and 
conduct evidence-based advocacy with 
policymakers.
If required, conduct operations research, 
feasibility and/or acceptability studies.
Include ECPs in FP guidelines and other 
policy documents and plan for its phased 
introduction. 
Conduct a diagnostic assessment for the 
introduction/reintroduction of ECPs
Diagnostic assessments are a critical pre-
introduction stage and should include multi-
sector consultations and dialogue to identify 
potential challenges and sources of resistance 
to ECP products and services. As a multi-party 
exercise, strategic assessments contribute 
towards generating knowledge, supporting 
consensus among country participants, 
and extending decision-making beyond the 
government. The assessment should include 
stakeholder and expert consultations, as well as 
qualitative and quantitative surveys to evaluate 
the perspective of decision makers, providers, 




Introducing ECPs through the 
Yuzpe regimen
It is possible to introduce ECPs in 
countries without registered dedicated 
products by using the Yuzpe regimen, 
which involves provision of combined 
OCPs that are already registered for 
contraceptive use in most countries 
worldwide. In some Latin American 
countries, initial advocacy efforts included 
national and international seminars and 
workshops to present the Yuzpe method 
and generate buy-in from relevant actors, 
including policy makers and NGOs. As 
a consequence, the Yuzpe regimen was 
included in the official family planning 
service delivery guidelines in Brazil, 
and other countries, before dedicated 
products were available (Vernon 998; 
Diaz et al. 007).

and users. Sources of information for the 
assessment can include, among others, DHS 
surveys and other national and international 
research, policy documents, key informers in 
service delivery, policy, women’s health advocacy, 
and legal aid organizations. The assessment 
should:
Help programs to understand the 
existing family planning policies and 
organization of services, to make 
recommendations on where ECPs could 
be offered, who could offer it, how to 
identify and train providers, which IEC 
materials would be needed, and how to 
include ECPs in commodity procurement 
and distribution processes, and within 
the management information system. 
The assessment should also determine if 
any policies would need to be updated, 
as well as the process for changing these 
policies, and how best to incorporate 
ECPs into the national FP service delivery 
guidelines.
Provide data to support the case for 
why ECPs would be useful within this 
population by describing current national 
levels of unprotected sex, proportions 
of unintended pregnancies, incidence of 


unsafe and safe abortions, incidence of 
rape, and method failure rates, among 
others.
Identify specific populations that could 
benefit from the introduction of ECPs 
and the feasibility of reaching these 
populations through various service 
delivery systems. As with most national 
RH programs, vulnerable sectors of the 
population, such as young women, the 
urban poor, and displaced and refugee 
populations, are harder to reach.
Collect information to help understand 
the cultural context and sensibilities 
around ECPs, which groups could 
potentially oppose its introduction as 
well as which reasons they may use and 
the types of messages that could be used 
to properly inform decision-makers.
Identify the most relevant stakeholders 
who could partner with programs in 
advocacy efforts and who should be 
provided information on ECPs. In several 
countries these have included not only 
reproductive health service delivery 
organizations, but also women’s health 
organizations, members of the legislative 
and judicial powers, and the media.  



Using evidence to demonstrate ECP acceptability
In Bangladesh, research demonstrated that  percent of pregnancies were unintended due to method 
failure or unprotected sex. Many of these pregnancies resulted in abortions performed in unsafe conditions 
leading to possible complications or death. Unprotected intercourse is common and frequent. These facts 
supported the introduction of ECP into the national program as a backup method for existing family planning 
methods (Khan and Hossain 00).
In Ghana, the national IPPF affiliate facilitated the introduction of ECPs into the public sector by undertaking 
a pilot to demonstrate user acceptability of ECPs, training providers, initiating demand creation activities, 
supporting the registration of a dedicated product, and ensuring its availability by procuring and distributing 
it to providers in both the private and public sector (Osei 007).
In Mexico, the introduction of ECPs into the public sector needed intensive advocacy efforts for almost 
a decade and required an external review of scientific evidence to prove that ECPs are not abortifacients. 
Support from feminist groups and other NGOs, as well as from individual MOH officials, were also factors 
that led to its introduction (Lara et al. 007).  
The Government of Nepal relied on IEC materials developed in Bangladesh and India and on technical 
assistance from the Population Council and a national research institution, the Nepal Fertility Care Centre, 
to introduce ECPs in a phased manner (Sherestha, Khan, and Hossain 008).
In Pakistan, program managers were concerned about a possible backlash from conservative Muslims 
when introducing ECPs. Consequently, introduction of the method began only after a study tour by key 
stakeholders to Bangladesh, another country with a predominantly conservative Muslim population, to 
observe how it was provided and to gauge the population’s response to its introduction (Khan et al. 008a). 
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Partner with stakeholders and conduct 
evidence-based advocacy with policymakers
NGOs and research institutions across the 
world have played an important role in 
encouraging governments to introduce ECPs 
into their reproductive health services. They 
have done this by providing policymakers 
with scientific information that presents a 
rationale for the introduction of EC and by 
sharing experiences of other programs. NGOs 
also typically play a critical role in ensuring 
EC supplies during introductory pilot projects, 
convening stakeholders, developing training 
curricula and providing training, facilitating 
guidelines on ECPs, and conducting diagnostic 
assessments. The likelihood of introducing and 
mainstreaming ECPs in the public sector is higher 
when done in partnership with organizations 
that have influence within government bodies, 
enjoy credibility for being honest, and maintain 
scientific rigor in their work. In the absence of 
substantial public sector involvement, ECPs may 
become the sole responsibility of NGOs or the 
private sector. As the former usually have limited 
coverage and the latter responds to market 
forces, this may mean that ECPs will not be 
available nationally and/or for those with specific 
needs, as is the case in Nigeria (Apsel 2007). 
If required, conduct operations research, 
feasibility and/or acceptability studies
In several countries in Asia, Africa and LAC, 
diagnostic, social science, and operations 
research have been undertaken to provide 
policymakers with evidence regarding the 
feasibility and acceptability of ECPs. Without 
this evidence, it would not have been possible to 
revise existing policies, design an introductory 
strategy, or ensure that introduction of ECPs will 
not lead to controversies or backlash. When the 
results of feasibility studies, operations research, 
and program experiences from neighboring 
countries are convincing and credible, there may 
be no need to conduct additional studies. 
Include ECPs in FP guidelines and other policy 
documents and plan for its phased introduction
The inclusion of ECPs into service delivery 
guidelines is an important aspect of the 
introduction process, especially if the method is 
to be mainstreamed. This process may involve 
a period of advocacy, technical assistance, 
and strategic planning by stakeholders and 
reproductive health experts. In some countries, 
such as Mexico, new contraceptives cannot be 
introduced into public sector programs until 
Using evidence to increase ECP availability
In Bangladesh, policymakers questioned the social acceptability of the method and needed to understand 
the operational changes needed for introducing ECPs into the public health system. A formative study 
followed by operations research showed that women would use the ECPs if they were made available, that it 
was feasible to introduce ECPs into the government’s program, and that paramedics as well as community 
workers could provide ECPs. These results facilitated the required policy change and the introduction of ECPs 
into the National Family Planning Program (Khan and Hossain 00).
In India, ECPs were initially available only by medical prescription, which limited their use. The medical 
profession opposed making ECPs an over-the-counter (OTC) drug, which prevented paramedics from 
providing them. Policymakers requested research to show that paramedics and public extension workers 
could provide services of a similar quality to physicians. The study results supported this, and policymakers 
were willing to change national policy to make ECPs available over-the-counter (Kumar et al. 007).
In Latin America, seven countries approved ECPs after MOH and NGO program managers attended a 
conference to review the results of operations research projects in other countries as well as other scientific 
evidence. They also received technical assistance to adapt the method in their service delivery guidelines and 
systems (Vernon 998).
Despite nearly a decade of public sector provision, ECP use in Kenyan clinics and hospitals remained 
limited.  To assist the MOH in meeting its dual goals of ensuring ECP access for adolescents and sexual 
assault survivors, the Population Council conducted a national assessment of public sector providers and 
facilities.  It found that ECP services were biased toward sexual assault survivors and that the majority of 
providers were not sufficiently trained to offer ECPs in the context of family planning.  In response, the MOH 
launched efforts to strengthen pre-service training on ECPs in medical and nursing schools, and to deliver 
contraceptive technology updates to in-service providers (Keesbury, Owino, and Bradford 007).
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they have been included in the national service 
delivery guidelines, and the changes have been 
made official by publication in the official 
gazette. (In the private sector, however, standard 
drug registration regulations apply.) As has been 
the situation in Bangladesh and Kenya, if staff 
from the organization leading the introductory 
activities can work closely with the government 
(such as serving on its technical committees), 
opportunities arise for making changes to the 
guidelines and teaching curricula. 
Step 3. 
Training and building the capacity 
of ECP providers
Training service providers is a vital component 
for introducing and mainstreaming ECP services. 
In many contexts, particularly in larger countries, 
training can be costly and logistically challenging. 
The following section suggests various training 
strategies that can be adopted according to 
need and context, which will help to build the 
overall capacity of the RH system to organize and 
monitor training for introducing ECPs.
Who should be trained
What information a provider needs to 
know
Strategies for training service providers
Strategies for mainstreaming training in 
ECPs
Who should be trained
Providers of ECPs will differ in each country, 
depending on the whether they are being 
introduced through the public or private sectors, 
through clinics, pharmacies, outreach workers, 
or non-medical staff, as well as the regulations, 
cultural context, and preferences of key target 




populations. In both the public and private 
sectors, the following have been instrumental in 
providing EC information and services to women 
(PATH 2004):
Nursing  and midwifery staff
Physicians
Paramedics
Trained community health workers
Adolescent peer educators
Private sector pharmacists and pharmacy 
counter staff
Gender-based violence (GBV)/rape 
survivor counselors and legal assistance
Police and forensic medical personnel








Content of typical stand-alone 
training session
First session: Overview of the demographic 
and reproductive health situation and 
discussion of the role of EC as a reproductive 
health intervention.
Second session: Definition of EC, and 
discussion of when and how ECPs should be 
taken.
Third session: Service delivery guidelines on 
how to provide ECPs, according to client’s 
particular needs.
Fourth session: Counseling on ECPs, 
monitoring and logistics management, and 
frequently asked questions.
Example from Bangladesh (Khan and Hossain 008)
Stand-alone training
In Zambia, stand-alone training was used to provide police officers with the skills to deliver ECPs 
to sexual assault survivors. As non-medical personnel, their training required more time than 
health care providers. This training was conducted through a five-day course that followed a 
condensed version the MOH’s curriculum for community/employer-based distributors. It focused 
on the essentials of reproductive physiology, contraceptive technologies, sexual assault response, 
integration with other services, and client/survivor counseling (Keesbury, Aytenfisu, and Bradford 
007). 
In Bangladesh, stand-alone training was used when training the entire cadre of family planning 
providers (more than ,000 providers). Senior program managers and district level officials were 
also oriented on ECPs before training of trainers and service providers. Initially, a group of master 
trainers was developed to train a large number of trainers, and the stand-alone training was then 
rolled out using a cascaded approach (see opposite page) (Khan and Hossain 008).
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What information a provider needs to know
A training curriculum should include essential 
information about ECPs, an update of other 
contraceptive methods, related reproductive 
health issues such as STIs/HIV, and counseling 
on the importance of bridging to regular 
contraception and provision/referral for services 
(PATH 2004).  Clinic and community health 
providers should also be trained to include 
ECPs in all FP counseling sessions and health 
education activities. The content, focus, and 
range of information communicated during 
the training will vary according to the type of 
provider. For instance, FP staff may require 
additional information on bridging to further 
FP and STI services, while pharmacists may 
benefit from advice on providing a confidential 
service. Capacity-building can start even before 
the registration of a dedicated ECP product, as 
combined OCPs are available in most countries 
and can be used for the Yuzpe regimen prior to 
the introduction of a dedicated ECP product.
Strategies for training service providers
Stand-alone/targeted	training. Training 
specifically on ECPs is an effective means 
of building the capacity of specific 
groups of providers so that they have a 
comprehensive understanding of ECPs. 
This type of training can usually be done 
in a short period of time in a classroom 
setting for those providers who already 
have a basic understanding of and 
competency in providing FP services. 
Unfortunately, it can prove expensive, 
as it needs a distinct budget and may 
not be the best option for providers who 
cannot easily leave their place of work. 
This strategy may not be appropriate for 
scaling up the ECP program throughout a 
national public health system unless the 
required funds are available.

Innovative training materials
In Venezuela, ProSalud InterAmericana, a national 
NGO, has created an interactive CD that is 
distributed cost-free to service providers for their 
self-training on ECPs. The disc has been used by 
NGOs and MOHs in several countries in the region 
(Martin 00). For a demo of the CD, see http://
www.prosaludinteramericana.org/esp/cd/demo.
html. 
The Central Board of Health in Zambia, with NGO 
partners, developed a self-directed training manual 
on “Family Planning in Reproductive Health,” 
which included a module on ECPs and counseling. 
Testing the approach demonstrated that it was as 
comprehensive as classroom training, although 
providers required 0- weeks to complete the 
course at their own pace (Keesbury 007).
Integrated training 
In India, the MOH adopted an integrated approach to train 00,000 health workers on ECPs because 
of the prohibitive cost of organizing stand-alone training. ECP training was integrated into the 
Reproductive and Child Health training program under which paramedics undergo three days of 
training. All paramedics were then reoriented in the new service, through a two-hour	session on 
ECPs. Subsequently, ECPs have been included in the MOH Contraceptive Technology Update (CTU) 
manual.
 
The integrated training methodology has also been successfully adopted in Guatemala, El 
Salvador, and Kenya.  In Kenya, ECP services were strengthened as a component of regular 
national CTU trainings provided by the Ministry of Health.  This strategy ensured that ECPs were 
considered an essential component of routine family planning and reproductive health services and 
not as an additional burden on service providers.  
Integrated	training. Training on ECPs 
can be integrated with other training 
opportunities, such as contraceptive 
technology updates or other training 
on RH issues. This strategy can be 
more cost-effective than stand-alone 
training and can reach a large numbers 
of trainees, but it is important to ensure 
that the depth and quality of the training 
are not compromised. The major limiting 
factor is that it can only be used if other 
training opportunities exist that are 
timely and for the appropriate type of 
providers.
Self-directed	training.	Self-directed 
training is a tool that is used for 
distance education provided either 
completely or partly outside of a central 
facility. It requires supervisory support, 


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but may prove an effective option 
in circumstances where there are 
inadequate resources for stand-alone or 
integrated training, or where providers 
are unable to leave their work stations. 
Strategies for mainstreaming training in ECPs
All three training strategies described above 
are suitable when introducing ECPs, and can 
be developed, tested, and revised through 
introductory pilot-testing. Once ECPs have 
been successfully introduced into the national 
program, which is usually on a small scale, a 
different training strategy is usually needed 
to mainstream ECPs throughout a national RH 
system. Three approaches can be recommended:
In-service	cascaded	training. Cascaded 
training can be a cost-effective means 
to reach large numbers of providers 
with in-service training. It can be used 
with either a stand-alone or integrated 
training curriculum, depending on 
whether there are funds available for 
supporting an ECP-specific training 
program (as was the case in Bangladesh, 
with funding provided by the 
Government, UNFPA, and USAID). There 
may also be regular training programs 
(for example, CTUs and the RCH program 
in India) into which ECP training can be 
integrated. 
 
When designing a cascaded training 
strategy for a large-scale public program, 
it is advisable to develop a cadre of 
Master Trainers who can then train 
the trainers themselves. The Master 
Trainers and trainers are then available 
to build the capacity of service providers 
throughout the system. In Bangladesh, a 
total of 300 Master Trainers and 2,300 
trainers were used to build the skills 
of 45,000 service providers (Khan and 
Hossain 2008). The cascaded training 
strategy is dependent on the funding 
available, the motivation and availability 
of all groups of trainers, and a consistent 
level of supervisory support to ensure 
that the training at all levels is of 
acceptable quality and occurs as planned.

Pre-service	training	in	EC	by	training	
institutions.	The most cost-effective 
way to mainstream ECPs, certainly over 
the long-term, is to integrate them into 
pre-service training for personnel who 
will likely provide them as part of their 
work. The incorporation of ECPs into 
the curricula and training manuals of 
medical training institutions (such as 
medical schools, pharmacy schools, 
nursing schools, and paramedic training 
courses) is critical to institutionalize ECP 
training and secure its sustainability in 
the health system. This approach will 
also ensure that ECP training is provided 
to medical professionals working in both 
the public and private sectors.
Quality	assurance	and	refresher	
training. Follow-up training is an 
important aspect of ongoing quality 
assurance. Refresher training, which 
can be done during routine supervisory, 
monitoring, and/or quality assurance 
visits by supervisors, should review 
and emphasize the key elements of 
delivering ECPs, as well as update 
providers on any recent developments 
and amendments to service delivery 
guidelines. Particular attention should 
be paid to ensure that providers are not 
letting personal biases prevent them 
from offering information and providing 
appropriate counseling, that they are 
emphasizing the need for bridging to 


Integrating ECPs
into pre-service training
In Kenya, ECP advocates assisted in the 
review of the family planning curriculum 
of the National Medical Training College, 
providing the resources and technical 
expertise needed to strengthen instruction 
on ECPs. To support this new emphasis, the 
Population Council is providing a refresher 
course on EC for tutors nationwide.
In Bangladesh, a chapter on ECPs has been 
incorporated in the national contraceptive 
manual, which is the reference book for 
all paramedics and medical professionals 
working in the family planning sector.
Similarly, in India, ECPs have been 
incorporated in all MOHFW training 
manuals, such as contraceptive technology 
updates and a handbook for introducing 
adolescent-friendly clinics for reproductive 
and sexual health. 
Steps for cascaded training  
in the public sector in Bangladesh
Train a group of Master Trainers, who then…
Train a group of trainers, who then…
Train the service providers

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regular contraception, and that they are 
screening for other RH needs, especially 
for STI/HIV management. For example, 
in Bangladesh, all supervisors have been 
instructed to ask questions about ECP 
services during visits and to conduct a 
15-minute discussion during monthly 
staff meetings. Provision of ECPs is now 
included in the ministry’s MIS system.
Step 4.  
Making the case for and raising 
public awareness of ECPs
Raising public awareness about EC is a critical 
introductory step to ensure that the target 
populations, general and specific, are aware 
of the method, know how it works, and know 
where to obtain ECPs. Key messages and means 
of communication are described here for further 
detail and guidance (see box on opposite page).
Experience has shown that the following 
components will usually be necessary in any 
efforts to ensure that the potential users are fully 
aware of ECPs, that possible opponents can be 
educated on the benefits of ECPs, and that a case 
can be made for including ECPs in the national 
RH program.
Understand the social, cultural, religious, 
and legal context.
Select communication channels based on 
their audiences.
Use the media to reach specific 
audiences.
Develop the key messages.
Understand the social, cultural, religious, and 
legal context
The legal regulations in the country about where 
and how ECPs may be promoted need to be 
well understood. Many countries do not allow 
messages on contraception in the media or 
restrict the content and schedule of messages. 
For example, many Muslim countries prohibit 
advertising of family planning methods in general 
or of the condom in particular. It is also essential 
to understand the social, religious, cultural, and 
political environment of the country to avoid 
creating unnecessary controversies.
ECPs are relatively easier to introduce and 
mainstream in settings with higher levels of 
contraceptive knowledge and use. When a large 
proportion of couples are already protected by 
reliable contraceptive methods, however, the 
potential impact of a successfully introducing 
ECPs can seem marginal to decisionmakers. In 

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such cases, the rationale for introducing ECPs 
into a country should be framed in terms of 
meeting the needs of couples who experience 
method failure as well its role in post-rape 
care. In Bangladesh, where 60 percent of the 
population uses contraception, one-third of 
pregnancies are unintended and usually occur 
due to method failure. Similar arguments have 
worked well in Nepal and Pakistan.
Knowledge and awareness about ECPs among 
both providers and potential clients in all regions 
of the world is still quite low. Consequently, 
mass media campaigns to rapidly increase 
awareness and correct knowledge of ECPs at the 
population level can significantly and quickly 
increase the use of ECPs. The success of mass 
media campaigns, as seen in India, Kenya, 
and various countries of Latin America, was 
demonstrated in the sharp increase in ECPs sales 
in urban areas after advertising started. Short 
periods of widespread exposure to the correct 
information can be as effective as long-lasting 
media campaigns that target specific and/or 
geographically limited populations.
Select communication channels based on their 
audiences
The two primary audiences for mass media 
campaigns are potential users of ECPs and those 
who can advocate and provide information, 
counseling, and services. An assessment 
of the mass media available in the country, 
including their policies on the advertisement 
of contraceptive products and the types of 
audiences they reach, is essential before deciding 
to use this channel.
Resources for outreach on ECPs
Pathfinder:
Emergency Contraceptive Pills, 2nd edition.  
http://www.pathfind.org/site/DocServer/
ECP2ed_for_web.pdf?docID=10203
PATH: 
Resources for emergency contraceptive pill 
programming: a toolkit 
www.path.org/files/RH_ec_toolkit.pdf
International Consortium for Emergency Contraception: 
Adapting Resource Materials for Local Use. 
www.cecinfo.org/files/Adapting-materials.rtf
Materials for EC Advocacy – Questions and 
Answers for Decision Makers 
www.cecinfo.org/files/QA-for-Decision-Makers.rtf
Materials for EC Clients 
www.cecinfo.org/files/Sample-Mtrls-for-Clients.rtf

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It is possible to reach different audiences and 
communicate different messages depending 
on the media used (print, radio, television, or a 
combination). Such an assessment can be made 
by considering the following media outlets and 
opportunities available:
Newspapers, magazines, radio stations, 
and television channels publish 
information on contraceptive methods, 
reproductive health, gender, and 
women’s empowerment. In Bangladesh, 
for example, journalists received 
information about ECPs and wrote 
articles during the pre-introduction 
period. In India, pharmaceutical 
companies used TV advertisements to 
make the public aware of ECPs.
Publicity and communications agencies 
can help to determine the channels, 
timing, frequency, and the duration 
of a planned campaign. They can also 
help develop and deliver the campaign 
messages. In some countries, such as 
Mexico, these firms have agreed to work 
on a pro-bono basis.  In others, such 
as Kenya, Ghana and Ethiopia, social 
marketing firms have launched media 
campaigns intended to increase sales 
primarily in the private sector.
Producers and scriptwriters of soap 
operas and other entertainment 


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programs could integrate EC into 
their storylines. In Mexico, a press kit 
on ECPs was sent to various media 
companies with suggestions on how to 
use the material based on examples from 
different countries. The script writers of 
one of the most popular soap operas at 
the time (Mirada de Mujer [A Woman’s 
Glance]) introduced ECPs into the plot 
of the program, following the lead of a 
similar incorporation in ER, the popular 
medical series in the US. 
Community-based channels – such as 
community radios, community theatres, 
and youth groups – could potentially 
include ECPs in ongoing activities.
Health and family planning telephone 
and internet hotlines can provide 
information on ECPs.  In Kenya, 
counselors working at an HIV/RH 
information hotline have been trained to 
answer questions on ECPs and provide 
referrals to other methods or services, 
such as VCT or post-rape care. In 
Bangladesh, pharmaceutical companies 
used hotlines to provide answers about 
their ECP products and how to use them.
Mass mailings: brochures, scientific 
articles, posters, and other printed 
materials can be sent to target audiences 
such as private physicians, pharmacists, 
women’s health organizations, schools 


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Strategies for engaging the mass media
ECafrique has worked extensively with media partners to transform the public discourse on EC.  In conjunction 
with a Kenyan media group, it prepared a “rapid response” kit to help journalists and NGOs respond to incorrect 
media reports and to inform articles supportive of EC and supported a four-day skills-building workshop for  
leading health reporters from East and Southern Africa. The workshop led to over 0 stories on EC and other RH 
issues featured in print, radio, television, and the vernacular media (ECafrique 00).
In Mexico, a press kit was sent to mass media organizations that covered health issues. Subsequently, more 
than  articles were published in national magazines and newspapers, six notes given on radio programs, and 
one mention in a national news program; ECPs were also included in the plot of a soap opera. It was estimated 
that this simple resource helped to reach .8 million persons, at a total cost of less than $US ,000 (Givaudan, 
Fuertes, and Vernon 998).
Likewise, in India and Bangladesh the media played a positive role by publishing articles highlighting and 
supporting the need to introduce ECPs into the national reproductive health program. Extensive media coverage 
in India, which followed an advocacy project supported by the Packard Foundation, played a pivotal role in the 
subsequent approval of ECPs (Khan and Hossain 008).
The press in Argentina covered the announcement of free government provision of ECPs and supported its 
introduction in university health services. Newspapers also denounced legal challenges, arguing that the new 
policy affected the most vulnerable who could not afford to buy ECPs from a pharmacy (La Nación 007). 
The media have also been very actively involved in the public debate over public provision in Chile, adopting 
positions for, against, and neutral to EC (La Nación 00; La Nación 007; La Nación 008; Faúndes et al. 007).
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and universities, factories and assembly 
plants, and rape survivor care centers, 
among others. In Mexico, this strategy 
proved to be effective in increasing 
knowledge of ECPs among these groups. 
Further, it has been found that those who 
receive the IEC materials are likely to 
use them and to inform and train others 
(Givaudan, Fuertes, and Vernon 1997; 
Vernon and Llaguno 2001; Martin 2004).
Use the media to reach specific audiences
In Paraguay, through an alliance with PSI, the 
local IPPF affiliate Promesa conducted social 
marketing of Pronta®, a dedicated progestin-
only ECP product. At the beginning, extensive 
formative research was undertaken to develop 
the brand and marketing strategy; subsequent 
marketing efforts have primarily targeted 
service providers and youth. Promesa and PSI 
created an interactive CD of training materials 
for providers. Promesa also communicated 
with youth through a weekly radio program, 
a network of peer-educators/promoters, and 
other outreach facilitated by the internet and cell 
phone text messaging. Married women and men 
were also reached by integrating ECP messages in 
general, as well as information about Pronta® in 
particular, into Promesa’s sexual health activities 
(Martin 2004).
In the absence of a commercial advertising 
campaign, marked increases in awareness can 
and have happened when national debates 
spontaneously generate mass media coverage, 
especially when such exposure is achieved 
through coordinated public communications 
strategies. This has happened in Argentina, Chile,  
Colombia, and Mexico (La Nación 2007; La Nación 
2008).
In some countries, media coverage has been 
obtained through carefully planned public 
relations strategies, including several components 
such as press conferences, press releases, and 
widely distributed media kits. In other settings, 
media attention has been achieved through paid 
airtime by large-scale social or social-commercial 
marketing campaigns, as was the case of PSI’s 
promotion of Postinor in Venezuela (ICEC 2005).
 
Develop the key messages
Different messages need to be considered for 
each of these audiences when raising awareness 
about ECPs. The emphasis of the messages will 
vary depending on the audience, but all messages 
should have correct, science-based information.
For	potential	users	and	providers. It 
is important that they know which ECP 
options are available, how and when 
ECPs can be used, dosage and schedule, 
sources of supply, mechanisms of action, 
possible side effects and management, 
and the need to bridge to a regular 
effective method.
For	those	who	oppose	ECPs. It is 
important to communicate ECPs’ mode of 
action (i.e. that it is not an abortifacient), 
that its use does not lead to increased 
sexual activity or risky behaviors, and 
that it has a bridging role in encouraging 
regular use of more reliable contraceptive 
methods. 
The following steps may help in the development 
of effective messages for both groups:
Identify existing IEC materials on ECPs 
that could be adapted and used in 
educational campaigns.
Pre-test the messages for clarity, cultural 
sensitivity, and appropriateness, and 
ensure that they appropriately address 
the information needs of potential users, 
providers, and opponents.
Give only one to three messages at a 
time.

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Reacting to negative media
In Kenya and Botswana, media reports have suggested that increasing access to EC through 
pharmacies encourages adolescents to “eat ECPs like chocolates” (Okwemba and Anyona 00).  These 
reports, largely based on anecdotal evidence from a small number of pharmacists, have significantly 
threatened provision of ECPs in both countries. Reacting to these articles, policymakers became 
concerned that increasing availability of ECPs may encourage risky sexual behaviors in the context of 
high HIV prevalence. Advocates in both countries successfully lobbied against sustaining restrictions 
to access through personal communication and both governments are now working with ECafrique to 
develop strategies for ensuring responsible ECP provision in the private and public sector outlets.
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Step 5.  
Mainstreaming: Scale up and 
sustainable institutionalization of 
ECP services
Introduction of ECPs into a national RH program 
is usually undertaken as a pilot project; once its 
provision is proven to be feasible, the challenges 
are (1) mainstreaming delivery of ECPs by 
taking to national scale those practices that 
were demonstrated to be feasible and effective 
during the pilot phase, and (2) ensuring that 
they can be sustained on a routine basis so that 
ECPs become a standardized method within the 
range of services made available. Anticipating 
and planning for scale-up and sustainability 
should be included at the outset of planning; 
if not, the activities proposed may not be 
replicable at a larger scale or sustainable over 
time. This is a critical issue and particularly 
relevant for the introduction of ECPs, given the 
sensitivities concerning the method, even after it 
has been proven socially acceptable and feasible 
to provide. In Zambia, for example, despite 
the success of pilot efforts and subsequent 
introduction into national FP guidelines, ECPs 
remain unavailable in the public sector due to 
limited funds for contraceptive procurement. 
Similar barriers have been seen in Ghana, 
Ethiopia, and Nigeria, where the achievements of 
introductory efforts flagged at the mainstreaming 
phase (Muteshi and Keesbury 2007).  
There is no simple formula or framework for 
mainstreaming ECPs that could be described here, 
as each situation will determine how a successful 
pilot could best be scaled up. Key lessons drawn 
from a range of experiences with mainstreaming 
ECPs provide guidance on issues that should be 
considered, even before starting a pilot project.
Scaling up the delivery of ECPs should 
be one of the objectives when pilot-
testing its introduction. At the time of 
designing the  introduction, the intention 
should always be that, whatever model is 
developed for delivering ECPs on a small 
scale, it should also be appropriate for 
delivering the method at a national scale. 
Regardless of whether mainstreaming 
will be in the public, NGO, and/or private 
sectors, this objective will influence 
decisions on:
choice of delivery system or program 
through which to provide the method.
design of the model for delivering ECPs 
(i.e. who, where, which product, what 
informational messages).
1.
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funding for commodity procurement and 
delivery costs during and after the pilot 
phase.
The pilot intervention should address 
a felt need for the national program 
and have the potential to meet 
the needs of a substantially large 
population. For example, reducing 
unintended pregnancies and their adverse 
consequences is a priority for most 
health programs (including those due 
to method failure). In Bangladesh, about 
one-third of pregnancies every year are 
unplanned, and it is believed that most of 
these are terminated by unsafe abortion. 
Policymakers and program managers 
focused on the provision of methods 
to reduce the incidence of unplanned 
pregnancy. In Kenya, by contrast, 
policymakers were concerned about 
meeting the reproductive health needs of 
the country’s large adolescent population. 
Based on research demonstrating that 
adolescents are the most frequent users 
of ECPs, the MOH decided to strengthen 
ECP provision to that target population 
(Morgan 2007).
Delivery of ECPs in the national 
program does not require major 
changes in the existing system.  The 
prospect of having to make any major 
change in the existing FP delivery system 
will usually receive strong resistance 
from policymakers and program mangers, 
which reduces the likelihood of scaling 
up. Thus, ECPs should be introduced as 
one more option in the existing delivery 
system for contraceptives. For example, 
during introduction in Bangladesh, a one-
page client registration form was supplied 
for providers to complete. After six 
months this form was dropped because of 
the additional work required of providers; 
they suggested adding a column to their 
existing client register instead, and this 
adjustment was used during nationwide 
scale-up.
Program managers responsible for 
scaling up ECP delivery should be 
involved in planning and implementing 
the pilot phase. It is easier to convince 
those who will have decisionmaking 
responsibility for planning and funding 
the mainstreaming of ECPs, should the 
pilot phase prove acceptable and feasible, 
if they are fully aware of and support 
the introductory model being piloted.  If 
program managers do not have the time 
to get involved personally, they need 
to be briefed regularly and encouraged 

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to contribute ideas or administrative 
support. In Ethiopia, turnover in the MOH 
has frustrated mainstreaming efforts, 
as original champions of ECPs were 
replaced by less supportive officials. This 
has stalled mainstreaming in the public 
sector, although product registration 
achieved under the pilot has enabled 
expansion of ECP services in the country’s 
private sector.
Build strategic partnerships with 
organizations that can facilitate 
mainstreaming. Depending on 
the capabilities and resources of 
the organization(s) supporting the 
introductory and mainstreaming 
processes, partnerships with agencies 
that have specific technical expertise 
or credibility and/or donors with 
resources can be critical in successfully 
implementing both stages. In Bangladesh, 
with USAID funding, a group of 
organizations supported the Directorate 
General of Family Planning, including 
Population Council, JSI, and Pathfinder 
International. After its introduction, 
UNFPA became the main funding partner 
supporting the Government’s scale-up 
program. In Kenya, the William and 
Flora Hewlett Foundation is supporting 
a national initiative to mainstream ECPs 
in the public and private sectors. Under 
this initiative, the Population Council has 
partnered with PSI, Marie Stopes/Kenya, 
the Pharmaceutical Society of Kenya, 
various commercial distributors of ECP 
products, and UNFPA.
Scale-up should be conducted in a 
phased manner. Once a pilot project 
has proven that ECPs and the model for 
their delivery are acceptable and feasible, 
it is not advisable to move immediately 
to national level scale-up. Scaling up on 
a gradual basis is recommended as the 
immediate phase after piloting, as this 
gives the opportunity to review, and adapt 
and modify if necessary the procedures 
and practices developed during the pilot 
phase.  This first phase of the scale-up 
should be sufficiently large to learn about 
and fully understand the operational and 
management challenges of incorporating 
ECPs into the existing systems and to 
identify elements of the pilot model that 
are not replicable and should be left out 
(see diagram of the phased approach on 
the next page).
5.
6.
Careful planning and monitoring for 
procurement and logistical supply 
is essential. Logistical support is an 
important foundation for efficient 
ECP distribution, particularly during 
introduction and scaling up. The more 
common logistical problems experienced 
by large delivery systems may include: 
product registration and product 
procurement from manufacturers; 
poor distribution of ECP products or 
IEC supplies to service delivery points; 
or miscalculations of demand or 
procurement, leading either to stock-outs 
or over-stockages, resulting in expired 
products. In Bangladesh, for example, 
many facilities that received IEC materials 
did not distribute them to potential 
clients because experience with the public 
logistics system led them to believe 
that they would not get a re-supply on 
time. In Kenya, the MOH received a large 
consignment of ECP supplies prior to its 
integration into the logistics system and 
family planning registers; consequently, 
the supplies were not distributed 
systematically to provincial and district 
levels, often reaching facilities with no 
trained providers or procedures for 
resupply (Keesbury, Owino, and Bradford 
2007).
Plan and budget for long-term technical 
assistance for the mainstreaming 
process, preferably using personnel from 
the pilot and/or limited scale-up phases. 
The introduction of any new service into 
a large delivery system requires some 
adjustments and capacity building to 
ensure its successful assimilation. Simply 
communicating the finding that ECPs are 
acceptable and describing the model by 
which it was introduced and delivered to 
program managers will not enable them 
to adapt it into their systems. Sustained 
technical assistance needs to be planned 
and budgeted, using those familiar with 
the ECP delivery model, until national 
mainstreaming has been achieved. 
Withdrawing technical assistance before 
the method is fully mainstreamed can 
lead to partial introduction and even 
discontinuation of its provision. This was 
the case in Ghana, where the Planned 
Parenthood Association of Ghana (PPAG) 
supported MOH efforts to introduce EC in 
the public sector through a series of pilot 
projects.  The gains of this work, however, 
have not been widely replicated due to 
limited funding for PPAG’s continued 
technical support and advocacy (Osei 
2007).
7.
8.
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Close monitoring of services at the initial 
stage of mainstreaming has crucial 
value. All components of a project or 
initiative to introduce ECPs into a national 
RH program (training, counseling, 
distribution, and communication) need 
systematic monitoring and documentation 
for two equally important reasons: 1) to 
ensure that the introductory activities 
were implemented as planned and 
are functioning efficiently; and 2) to 
have a record of the facilitating factors 
and obstacles encountered during the 
introductory process so that appropriate 
action can be taken when scaling up 
and mainstreaming these introductory 
experiences. Monitoring training and 
developing support systems can be used 
to provide feedback so that plans for 
training after mainstreaming is complete 
can be based on these experiences. 
Routine monitoring using MIS data can 
9.
provide feedback once ECPs have been 
integrated into the family planning 
delivery system. These data can be used 
to identify service delivery points that 
need more training, supervision, or 
strengthening in general. Conducting 
rapid mid-term monitoring assessments 
(for example, after six months of service 
provision) can be useful to assess the 
quality of services provided—for example, 
whether new knowledge and skills have 
been retained.
Monitoring and occasional evaluation 
must be sustained once mainstreaming 
has been achieved. Three indicators can 
be used to determine when ECPs have 
been successfully mainstreamed in the 
system:
Inclusion of ECP products in the public 
health system’s essential commodities 
list so that there is a regular line item in 
the contraceptive procurement budget.
Inclusion of ECPs in the national 
contraceptive MIS system, which shows a 
commitment to monitor the performance 
of the program in terms of its capacity to 
deliver ECPs.
Documenting the number and proportion 
of providers and facilities reporting that 
stock and distribute or sell ECPs as one 
of their standard services or products.
 Monitoring should continue after the 
delivery of ECPs has been fully assimilated 
into public health, private, or NGO 
delivery systems. At this point the focus 
of monitoring shifts from documenting 
implementation of introductory activities 
to routinely measuring the delivery of 
ECPs as one FP service within the overall 
RH program. Special periodic surveys 
can provide important data on program 
performance–for example, through 
inclusion of questions or modules on ECPs 
in national and district-wide reproductive 
health surveys. In Kenya, such a survey 
was undertaken after nearly a decade of 
ECP service provision, allowing program 
managers to reflect on the success of 
their efforts and reorient strategies 
where necessary (Keesbury, Owino, and 
Bradford 2007). Furthermore, data on 
the bridging role of ECPs to increase 
regular use of FP will support recognition 
of ECP introduction and mainstreaming 
as an important reproductive health 
intervention.
10.
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A phased approach to introducing and 
scaling up ECP: The Bangladesh experience
Diagnostic studies: Qualitative needs assessment 
for ECP services 
OR to assess acceptability of ECPs and determine 
operational mechanisms for introducing ECPs 
Recommend appropriate strategies to the MOH 
based on OR results
Presentation of OR results at the national level 
to the media, program managers, researchers, 
educationalists, and representatives of NGOs 
Policy decision to introduce ECPs into the 
National FP program in two phases  
 
Phase I: Introduction of ECPs in Dhaka division 
covering a population of  million 
Development of IEC and training materials 
Training of ,007 providers and provision of 
services 
Monitoring of Phase I scale-up  
 
Phase II: Scaled up in the remaining divisions, 
covering a population of 89 million 
Continue monitoring and gathering feedback 
from clients on service delivery 
Necessary measures taken to improve service 
delivery and educate clients
.
.
.
.
.
6.
7.
8.
9.
10.
.
.
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